Meanwhile, silencing FUNDC1 reduces levels of IL-6 and TNF-α and inhibits CSE-induced mitophagy, cell apoptosis, and the progression of COPD [156]. The gene discussed is FUNDC1; the disease is chronic obstructive pulmonary disease.